Viewing Study NCT01337557


Ignite Creation Date: 2025-12-24 @ 6:48 PM
Ignite Modification Date: 2026-02-05 @ 11:51 PM
Study NCT ID: NCT01337557
Status: UNKNOWN
Last Update Posted: 2011-04-19
First Post: 2011-04-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Use of BEPREVE (Bepotastine Besilate Ophthalmic Solution) 1.5% for Allergic Conjunctivitis and Contact Lenses
Sponsor: Hom, Milton M., OD, FAAO
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Allergic Conjunctivitis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Allergic conjunctivitis View